Earlier Stage Biotechs Attract Partners  

Oleh:

Ratner, Mark

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: Nature Biotechnology: The Science and Business of Biotechnology vol. 23 no. 5 (Mei 2005), page 509.
Topik: biotechnology; biotech; partner

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: NN9.3 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Even as the environment for going public remains hostile to most biotech companies and their investors, some are discovering that favorable financing alternatives still exist. A spate of recent acquisitions and a continuation of early stage deal making signify that there are still appealing ways for many companies to sustain their drug development programs, especially given the needs of potential acquirers and licenses. For biotech whose lead programs are at or near the phase 2 clinical trial inflection point that validates proof of concept, potential partners increasingly are considering acquisition...

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali